Statement: Zantac (ranitidine) litigation
Issued: London, UK
For investors and media only
GSK plc (LSE/NYSE: GSK) today confirmed it has reached a confidential settlement in the Cantlay/Harper case filed in California state court. The case, which was set to begin trial on 13 November 2023,...
Zur Pressemeldung auf www.gsk.com